Soho Flordis International Pty Ltd. manufactures natural medicine products. Its brands include flordis, ProThera, COMPLEMENTARY, ginsana and KLAIRE LABS. Its products include ginsana, keenmind, nuvexa and gincosan. The company was founded in 2010 and is headquartered in St. Leonards, Australia.

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Omega Pharma Innovation & Development NV, part of Perrigo Co. Plc, is a company headquartered in Belgium. The firm engages in research and development in biotechnology.

SunOpta Ingredients, Inc. develops and sells proprietary health food ingredients. The company was founded in 1991 by Morgan Robert W and is headquartered in Edina, MN.

Sanofi is a global healthcare company. Among their duties are researching disease causes, determining starting points for drug treatment, developing drugs, producing active ingredients, and delivering finished drugs and active ingredients. Specialists in vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare.

GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA.

InQpharm Group is a Malaysian private company located in Kuala Lampur, also operating in GB. The firm develops pharmaceutical products.\nOn its website, the firm says this about itself: bmiSMART is a consumer weight wellness brand launched in 2016 by InQpharm North America, a regional division of InQpharm, based in Salt Lake City, Utah. InQpharm is a global life sciences company active in consumer and animal health, developing best in class healthcare solutions based on its proprietary bioactive-based platform technologies. InQpharm is part of the Zaluvida Group, which focuses on companies that discover and develop natural compounds with therapeutic properties for consumer health, animal health and crop science applications. With offices in Switzerland, Germany, Netherlands, UK, Malaysia, and the USA, Zaluvida's activities and customers span more than 55 countries worldwide.

Aventis Animal Nutrition SA manufactures nutritional feed additives for animal feed. The company is headquartered in Paris, France.

Raisio Benecol Oy provides plant-based nutrition food products. The company was founded in 1995 and is headquartered in Raisio, Finland

Phenex Pharmaceuticals AG was founded in 2002. It is a privately held drug discovery & development company based in the Biotech Cluster Rhine-Neckar with Biology and Chemistry laboratories and offices primarily in Heidelberg and partly in Ludwigshafen. Their company focuses its small-molecule drug discovery expertise in Liver and Gastrointestinal disease areas and has now recently entered the field of Cancer Therapy. They not only devise novel therapeutics for known targets but additionally aim to identify novel molecular mechanisms. This provides the basis for the identification of novel small molecules with "game changing" capabilities. Historically, Phenex has identified two of such novel mechanisms from literature and has translated them into proprietary novel therapeutic small molecules.

Liptosa is specialized in animal nutrition and disease prevention.They provide effective solutions to nutritionists, veterinarians and farmers in the animal nutrition sector.They do research on meeting the needs of different animal species in production scenarios.

Enzytech is a health care company that develops an injectable drug system for multiple sclerosis patients. The company is baed in Cambridge, Massachusetts.

Ceapro, Inc. engages in the development and marketing of natural products for personal care, cosmetic, human, and animal health industries. It operates through the Active Ingredient Product Technology Industry, and Cosmeceutical Industry segments. The Active Ingredient Product Technology Industry segment involves the development of proprietary extraction technologies and the application of these technologies to the production and development and commercialization of active ingredients derived from oats and other renewable plant resources for healthcare and cosmetic industries. The Cosmeceutical Industry segment develops and commercializes anti-aging products derived from natural active ingredients. The company was founded on May 12, 1987 and is headquartered in Edmonton, Canada.